Cytochrome P450, Family 2, Subfamily C, Polypeptide 9 (CYP2C9) ELISA Kits

CYP2C9 encodes a member of the cytochrome P450 superfamily of enzymes. Additionally we are shipping CYP2C9 Antibodies (58) and CYP2C9 Proteins (4) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
CYP2C9 1559 P11712
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top CYP2C9 ELISA Kits at

Showing 5 out of 22 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human 5.8 pg/mL 23.5-1500 pg/mL Typical standard curve 96 Tests Log in to see 15 to 18 Days
Rat 0.114 ng/mL 0.312-20 ng/mL 96 Tests Log in to see 15 to 17 Days
Human 0.1 ng/mL 0.312-20 ng/mL   96 Tests Log in to see 2 to 3 Days
  100 Tests Log in to see 2 to 3 Days
  100 Tests Log in to see 2 to 3 Days

More ELISA Kits for CYP2C9 Interaction Partners

Human Cytochrome P450, Family 2, Subfamily C, Polypeptide 9 (CYP2C9) interaction partners

  1. Data suggest that SNPs in CYP2C9 (*3, I359L; *30, A477T) that reduce catalytic activity of CYP2C9 also alter interaction with antihypertensive drug losartan; I359L substitution located far from active site remarkably alters residue side chains near active site and access channel, whereas the T477 substitution illustrates hydrogen-bonding interaction with reoriented side chain of Q214.

  2. SNP rs4918758 of CYP2C9 showed a suggestive association with decreased risk of coronary heart disease.

  3. CYP2C9*31075AC genotype with combined alcohol and nevirapine usage indicated a risk for development of antiretroviral-associated hepatotoxicity

  4. CYP2C9 polymorphisms showed no effect on PC doses. Similar findings were observed in the initiation phase of PC therapy. High complications rates under PC therapy were observed particularly at the beginning.

  5. Genetic variants of CYP2C9/VKORC1 (show VKORC1 ELISA Kits) and age are significant determinants of the maintenance dose of warfarin in patients with atrial fibrillation/valve replacement.

  6. CYP2C9*3 polymorphism genotype and allele frequency were not statistically different between the case and control Ankylosing Spondylitis groups (P>0.05). the efficacy of NSAID in treatment of AS and COX-2 (show COX2 ELISA Kits) gene -1290A/G and -1195G/A polymorphism were associated (all P<0.05), but it is not associated with CYP2C9 *3 polymorphism (all P>0.05).

  7. polymorphisms c.98T>C in the UGT1A9 (show UGT1A9 ELISA Kits) and c.1075A>C in the CYP2C9 genes did not affect the pharmacokinetic profile of propofol

  8. Possession of CYP2C9*2 and/or CYP2C9*3 allele variants is associated with lower time of international normalized ratio (INR (show INSR ELISA Kits)) in the therapeutic range (TTR (show TTR ELISA Kits)) values and warfarin dose variations in aortic valve replacement patients, the latter affected also by VKORC1 (show VKORC1 ELISA Kits) c.-1693G>A polymorphism

  9. Three SNPs (CYP2C9 *2, *3 and VKORC1 (show VKORC1 ELISA Kits) c.-1639G > A) were genotyped by electrochemical detection using a sandwich-type format that included a 3' short thiol capture probe and a 5' ferrocene-labeled signal probe.

  10. This study was aimed to describe the distribution of CYP2C9 and CYP2C19 (show CYP2C19 ELISA Kits) alleles and haplotypes in four Mestizo populations from Western Mexico. Frequencies ranged from 2.2-3.0% and 4.8-8.9% for CYP2C9*3 and CYP2C9*2 alleles, respectively, and 5.4-12.0% for CYP2C19 (show CYP2C19 ELISA Kits)*2, whereas the CYP2C19 (show CYP2C19 ELISA Kits)*3 allele was not found.

CYP2C9 Antigen Profile

Antigen Summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24.

Gene names and symbols associated with CYP2C9

  • cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9) antibody
  • CPC9 antibody
  • CYP2C antibody
  • CYP2C10 antibody
  • CYPIIC9 antibody
  • P450IIC9 antibody

Protein level used designations for CYP2C9

cytochrome P-450 S-mephenytoin 4-hydroxylase , cytochrome P-450MP , cytochrome P450 2C9 , cytochrome P450 PB-1 , flavoprotein-linked monooxygenase , microsomal monooxygenase , xenobiotic monooxygenase

1559 Homo sapiens
Selected quality suppliers for CYP2C9 (CYP2C9) ELISA Kits
Did you look for something else?